Sumayod, Gracelyn B.
HRN: 27-30-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 1.5GM (VIAL)
06/24/2025
06/24/2025
IVTT
1.5g
PTOR
For D&C
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: